First diagnostic results from Gothenburg-2 screening trial
DOI:
https://doi.org/10.2340/sju.v58.9397Downloads
References
Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa N, Nelen V, et al. A 16-yr follow-up of the European randomized study of screening for prostate cancer. Eur Urol. 2019;76:43–51. DOI: https://doi.org/10.1016/j.eururo.2019.02.009
Xie J, Jun C, Liu M, Sun K, Jin Z, Ding Z, Gong X. MRI/transrectal ultrasound fusion-guided targeted biopsy and transrectal ultrasound-guided systematic biopsy for diagnosis of prostate cancer: a systematic review and meta-analysis. Front Oncol. 2022;12:880336. DOI: https://doi.org/10.3389/fonc.2022.880336
Hugosson J, Månsson M, Wallström J, Axcrona U, Carlsson SV, Egevad L, et al. Prostate cancer screening with PSA and MRI followed by targeted biopsy only. N Engl J Med. 2022;387:2126–37. DOI: https://doi.org/10.1056/NEJMoa2209454
Eklund M, Jäderling F, Discacciati A, Bergman M, Annerstedt M, Aly M, et al. MRI-targeted or standard biopsy in prostate cancer screening. N Engl J Med. 2021;385:908–20. DOI: https://doi.org/10.1056/NEJMoa2100852
Auvinen A, Rannikko A, Taari K, Kujala P, Mirtti T, Kenttämies A, et al. A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale. Eur J Epidemiol. 2017;32:521–7. DOI: https://doi.org/10.1007/s10654-017-0292-5
Published
How to Cite
Issue
Section
License
Acta Chirurgica Scandinavica Society owns the copyright for all material published until Volume 57 (2023) unless otherwise specified. As from Volume 58 (2023) all published articles, unless otherwise specified, are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
